BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 24263317)

  • 1. Liver transplantation in highest acuity recipients: identifying factors to avoid futility.
    Petrowsky H; Rana A; Kaldas FM; Sharma A; Hong JC; Agopian VG; Durazo F; Honda H; Gornbein J; Wu V; Farmer DG; Hiatt JR; Busuttil RW
    Ann Surg; 2014 Jun; 259(6):1186-94. PubMed ID: 24263317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The evolution of liver transplantation during 3 decades: analysis of 5347 consecutive liver transplants at a single center.
    Agopian VG; Petrowsky H; Kaldas FM; Zarrinpar A; Farmer DG; Yersiz H; Holt C; Harlander-Locke M; Hong JC; Rana AR; Venick R; McDiarmid SV; Goldstein LI; Durazo F; Saab S; Han S; Xia V; Hiatt JR; Busuttil RW
    Ann Surg; 2013 Sep; 258(3):409-21. PubMed ID: 24022434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.
    Hayashi PH; Forman L; Steinberg T; Bak T; Wachs M; Kugelmas M; Everson GT; Kam I; Trotter JF
    Liver Transpl; 2003 Jul; 9(7):737-40. PubMed ID: 12827562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting outcome after liver transplantation: utility of the model for end-stage liver disease and a newly derived discrimination function.
    Desai NM; Mange KC; Crawford MD; Abt PL; Frank AM; Markmann JW; Velidedeoglu E; Chapman WC; Markmann JF
    Transplantation; 2004 Jan; 77(1):99-106. PubMed ID: 14724442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Live donor liver transplantation in high MELD score recipients.
    Selzner M; Kashfi A; Cattral MS; Selzner N; McGilvray ID; Greig PD; Levy GA; Renner EL; Grant DR
    Ann Surg; 2010 Jan; 251(1):153-7. PubMed ID: 19858705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of posttransplant Model for End-Stage Liver Disease (MELD) and delta-MELD scores on short-term outcome after living donor liver transplantation.
    Kim JD; Choi JY; Kwon JH; Jang JW; Bae SH; Yoon SK; You YK; Kim DG
    Transplant Proc; 2009 Nov; 41(9):3766-8. PubMed ID: 19917383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival outcomes in liver transplant recipients with Model for End-stage Liver Disease scores of 40 or higher: a decade-long experience.
    Panchal HJ; Durinka JB; Patterson J; Karipineni F; Ashburn S; Siskind E; Ortiz J
    HPB (Oxford); 2015 Dec; 17(12):1074-84. PubMed ID: 26373873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pediatric end-stage liver disease (PELD) model as a predictor of survival benefit and posttransplant survival in pediatric liver transplant recipients.
    Barshes NR; Lee TC; Udell IW; O'mahoney CA; Karpen SJ; Carter BA; Goss JA
    Liver Transpl; 2006 Mar; 12(3):475-80. PubMed ID: 16498644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of pretransplant MELD score on posttransplant outcome in orthotopic liver transplantation for patients with acute-on-chronic hepatitis B liver failure.
    Wang ZX; Yan LN; Wang WT; Xu MQ; Yang JY
    Transplant Proc; 2007 Jun; 39(5):1501-4. PubMed ID: 17580172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Avoiding Futility in Simultaneous Liver-kidney Transplantation: Analysis of 331 Consecutive Patients Listed for Dual Organ Replacement.
    Lunsford KE; Bodzin AS; Markovic D; Zarrinpar A; Kaldas FM; Gritsch HA; Xia V; Farmer DG; Danovitch GM; Hiatt JR; Busuttil RW; Agopian VG
    Ann Surg; 2017 May; 265(5):1016-1024. PubMed ID: 27232249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of liver transplantation outcomes in the pre- vs. post-MELD eras.
    Kanwal F; Dulai GS; Spiegel BM; Yee HF; Gralnek IM
    Aliment Pharmacol Ther; 2005 Jan; 21(2):169-77. PubMed ID: 15679767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Damage Control as a Strategy to Manage Postreperfusion Hemodynamic Instability and Coagulopathy in Liver Transplant.
    DiNorcia J; Lee MK; Harlander-Locke MP; Xia V; Kaldas FM; Zarrinpar A; Farmer DG; Yersiz H; Hiatt JR; Busuttil RW; Agopian VG
    JAMA Surg; 2015 Nov; 150(11):1066-72. PubMed ID: 26308380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MELD and prediction of post-liver transplantation survival.
    Habib S; Berk B; Chang CC; Demetris AJ; Fontes P; Dvorchik I; Eghtesad B; Marcos A; Shakil AO
    Liver Transpl; 2006 Mar; 12(3):440-7. PubMed ID: 16498643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Model for End-Stage Liver Disease (MELD) score and organ allocation from cadaveric donors for 198 liver transplantation procedures performed in a single center.
    Santori G; Andorno E; Morelli N; Casaccia M; Bottino G; Ghirelli R; Valente U
    Transplant Proc; 2008; 40(6):1903-5. PubMed ID: 18675084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influence of recipient pretransplant MELD-AS score and graft size on the outcome of adult-to-adult living donor liver transplantation].
    Feng X; Wei YG; Li FQ; Yuan D; Jiang H; Du ZG; Yin J; Li B
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):801-4. PubMed ID: 19024318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal utilization of donor grafts with extended criteria: a single-center experience in over 1000 liver transplants.
    Cameron AM; Ghobrial RM; Yersiz H; Farmer DG; Lipshutz GS; Gordon SA; Zimmerman M; Hong J; Collins TE; Gornbein J; Amersi F; Weaver M; Cao C; Chen T; Hiatt JR; Busuttil RW
    Ann Surg; 2006 Jun; 243(6):748-53; discussion 753-5. PubMed ID: 16772778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes after liver transplantation in patients achieving a model for end-stage liver disease score of 40 or higher.
    Alexopoulos S; Matsuoka L; Cho Y; Thomas E; Sheikh M; Stapfer M; Dhanireddy K; Sher L; Selby R; Genyk Y
    Transplantation; 2013 Feb; 95(3):507-12. PubMed ID: 23380865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re-weighting the model for end-stage liver disease score components.
    Sharma P; Schaubel DE; Sima CS; Merion RM; Lok AS
    Gastroenterology; 2008 Nov; 135(5):1575-81. PubMed ID: 18835388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicentric evaluation of model for end-stage liver disease-based allocation and survival after liver transplantation in Germany--limitations of the 'sickest first'-concept.
    Weismüller TJ; Fikatas P; Schmidt J; Barreiros AP; Otto G; Beckebaum S; Paul A; Scherer MN; Schmidt HH; Schlitt HJ; Neuhaus P; Klempnauer J; Pratschke J; Manns MP; Strassburg CP
    Transpl Int; 2011 Jan; 24(1):91-9. PubMed ID: 20819196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.
    Yi NJ; Suh KS; Lee HW; Shin WY; Kim J; Kim W; Kim YJ; Yoon JH; Lee HS; Lee KU
    Liver Transpl; 2009 May; 15(5):496-503. PubMed ID: 19399732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.